Detalhe da pesquisa
1.
Circumventing drug resistance in gastric cancer: A spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics.
Drug Resist Updat
; 74: 101080, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38579635
2.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Lancet
; 402(10408): 1133-1146, 2023 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499670
3.
Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
Cancer Immunol Immunother
; 73(7): 119, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713205
4.
Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Vancomycin in Patients with External Ventricular Drain.
Antimicrob Agents Chemother
; 67(6): e0024123, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162349
5.
Impact of low serum iron on treatment outcome of PD-1 inhibitors in advanced gastric cancer.
BMC Cancer
; 23(1): 1095, 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950201
6.
Integrated multi-omic data and analyses reveal the response pathways of to high-temperature stress.
Physiol Plant
; 175(6): e14112, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38148228
7.
Nano-selenium enhances melon resistance to Podosphaera xanthii by enhancing the antioxidant capacity and promoting alterations in the polyamine, phenylpropanoid and hormone signaling pathways.
J Nanobiotechnology
; 21(1): 377, 2023 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37845678
8.
Unveiling the mechanisms of peracetic acid activation by iron-rich sludge biochar for sulfamethoxazole degradation with wide adaptability.
J Environ Manage
; 347: 119119, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804630
9.
Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients.
Cancer
; 128(5): 995-1003, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878659
10.
Comprehensive Analysis of Cellular Senescence-Related Genes in Prognosis, Molecular Characterization and Immunotherapy of Hepatocellular Carcinoma.
Biol Proced Online
; 24(1): 24, 2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36536279
11.
Mechanistic Study on the Species Differences in Excretion Pathway of HR011303 in Humans and Rats.
Drug Metab Dispos
; 50(6): 809-818, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862251
12.
Pharmacokinetics, Mass Balance, and Metabolism of the Novel Urate Transporter 1 Inhibitor [14C]HR011303 in Humans: Metabolism Is Mediated Predominantly by UDP-Glucuronosyltransferase.
Drug Metab Dispos
; 50(6): 798-808, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862252
13.
Mechanistic Study on the Effect of Renal Impairment on the Pharmacokinetics of Vildagliptin and its Carboxylic Acid Metabolite.
Pharm Res
; 39(9): 2147-2162, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790618
14.
Furmonertinib (Alflutinib, AST2818) is a potential positive control drug comparable to rifampin for evaluation of CYP3A4 induction in sandwich-cultured primary human hepatocytes.
Acta Pharmacol Sin
; 43(3): 747-756, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34035488
15.
Metabolic disposition of the EGFR covalent inhibitor furmonertinib in humans.
Acta Pharmacol Sin
; 43(2): 494-503, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33927359
16.
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.
Lancet Oncol
; 22(7): 977-990, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34143971
17.
Camrelizumab plus oxaliplatin-based chemotherapy as first-line therapy for advanced biliary tract cancer: A multicenter, phase 2 trial.
Int J Cancer
; 149(11): 1944-1954, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309846
18.
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703).
Oncologist
; 26(10): e1693-e1703, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34105207
19.
A Comparison of the Seventh and Eighth Editions of the AJCC Staging Systems to Predict Recurrence in Papillary Thyroid Microcarcinoma.
Ann Surg Oncol
; 28(11): 6564-6571, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33521903
20.
Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy.
BMC Cancer
; 21(1): 341, 2021 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789616